We are is pleased to announce that Dr. Ben Robertson has joined the team as senior director of Test Method Development and Analytics. Dr. Robertson is a highly accomplished biomedical engineer and scientist with 15 years of experience spanning defense, academia, biopharma, and medical devices. His expertise in test method development, analytics, and automation will be instrumental in ensuring the performance and safety of XCMR’s far UV-C disinfection technologies.
Dr. Robertson thrives at the intersection of scientific exploration and technological innovation. He is renowned for his ability to create novel experimental platforms that push the boundaries of commercially available systems. This unique skillset has equipped him to make significant contributions in diverse fields, including traumatic brain injury research, robotic exoskeleton development, drug discovery, and medical device evaluation.
At XCMR, Dr. Robertson will leverage his extensive knowledge and experience to address the challenges associated with developing and implementing test methods for UV-C disinfection technologies. His focus will be on scenarios where standard test methods are insufficient or inadequate to assess device performance accurately.
Dr. Robertson holds an undergraduate degree in Applied Physics from Emory University and a PhD in Biomedical Engineering from the joint department at UNC Chapel Hill and NC State University. His career path includes notable positions at the Walter Reed Army Institute of Research, Temple University’s Spence Lab, Edgewise Therapeutics, and Exponent Inc. He is proficient in a wide range of engineering and biological competencies, further demonstrating his versatility and ability to tackle complex challenges.
